Background: Proteinuria is a marker of poor outcomes in several diseases; however, few studies have been conducted to explore the prognostic value of proteinuria, assessed by urine dipstick test, for clinical outcomes in patients with type B acute aortic dissection (TBAD) undergoing thoracic endovascular aortic repair (TEVAR). Methods: Consecutive patients with TBAD undergoing TEVAR were enrolled from January 2010 to July 2015. Proteinuria was defined as trace or higher, according to the results of urine dipstick testing. Associations among proteinuria and adverse events were evaluated. Results: In total, 671 patients with a mean age of 44 ± 15 years were included in the analysis. Proteinuria was detected in 281 patients (41.9%) before TEVAR. Multivariate logistic regression analysis showed that C-reactive protein and impaired renal function were independent predictors for proteinuria. During hospitalization, 21 patients died. In-hospital mortality was higher in patients with proteinuria (1.5% vs. 5.3%, p = 0.005). After a median 3.4 years follow up, the post-TEVAR death rate was 10.4% (85 patients were lost to follow-up). The long-term cumulative mortality was significantly higher in patients with proteinuria (17.2% vs. 8.2%, log-rank = 11.36, p = 0.001).
Introduction
Type B acute aortic dissection (TBAD) is a vascular emergency with a high risk of death, despite advances in diagnostic and therapeutic techniques [1] . Thoracic endovascular aortic repair (TEVAR) is an effective procedure for treating TBAD, which decreases the incidence of both short-and long-term mortalities [2] ; however, the postoperative death rate remains high, particularly during long-term follow-up. According to epidemiological evidence, the 5-year all-cause mortality is estimated at 10% [3] . Hence, early risk stratification of patients with TBAD is crucial to identify the high risk group and accordingly provide them with additional follow-up care with the aim of improving outcomes.
Proteinuria, an indicator of impaired kidney function, is associated with increased risks of both acute kidney injury and cardiovascular mortality [4, 5] . In a study by Tolenaar et al. [6] , renal failure was identified as an independent predictor of in-hospital mortality in patients with acute TBAD. Dipstick urinalysis is a convenient and widely applied method for the assessment of proteinuria [7] ; however, few studies have been conducted to explore the prognostic value of proteinuria for clinical outcomes in patients with TBAD undergoing TEVAR. The present study was performed to investigate whether proteinuria, assessed by urine dipstick test, can provide predictive information on unfavorable outcomes in this population.
Materials and methods

Study population
This retrospective observational study was conducted in two centers, including Shenzhen Second Hospital and Sichuan Provincial People's Hospital. Consecutive patients with TBAD undergoing TEVAR were enrolled from January 2010 to July 2015. TBAD was diagnosed using multispiral computed tomography. Patients with chronic aortic dissection (AD) were not included. In addition, those with AD caused by trauma, iatrogenic injury, intramural hematoma or Marfan syndrome were excluded. We also excluded patients with a history of malignancy and without available pre-TEVAR urine dipstick test results. Furthermore, patients with active urinary tract infection and positive hematuria were excluded from the analysis. The study was approved by the Institutional Ethics Committee, with a waiver of informed consent due to retrospective study design.
Laboratory examinations and data collection
Urine samples were collected on the morning after admission. Urinary protein was measured by qualitative dipstick using an AUTION MAX AX-4280 analyzer (Kyoto, Japan). Test results were negative, trace, 1+, 2+ and 3+. Proteinuria was defined as trace or higher. In addition, C-reactive protein (CRP), D-dimer (DDI), serum creatinine and other standard parameters were measured on hospital admission. All clinical data were collected from electronic patient records. Hypertension and diabetes were defined with documented history and diagnosis on discharge. Estimated glomerular filtration rate (eGFR) was calculated according to the equation of Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) [8] .
Follow-up and outcomes
All patients were followed up by telephone interviews after discharge in a specified time period from January 2016 to April 2017. Long-term all-cause mortality was the primary end point. We also recorded inhospital major adverse clinical events (MACEs), including death, stroke and dialysis while in hospital.
Statistical analyses
In this study, mean ± standard deviation or median (interquartile range) was used to describe continuous parameters. Number (percentage) was used for categorical variables. Continuous data were compared using analysis of variance or nonparametric statistical tests, whereas categorical data were evaluated using chi-square tests. Univariate and multivariate logistic regression analyses were performed to identify risk factors for proteinuria. Relationships among all clinical variables and long-term death were evaluated by univariate Cox regression analysis, and variables with p-values <0.05 were included in a multivariate Cox proportional hazard model for further analysis. Survival and time-to-event curves were analyzed by the Kaplan-Meier method, and the results were compared using the log-rank test. A two-sided p < 0.05 was considered statistically significant. All statistical analyses were performed using the Statistical Package for the Social Sciences version 13.0 (SPSS Inc., Chicago, IL, USA).
Results
In total, 671 patients with TBAD undergoing TEVAR were included in the analysis; the mean age was 44 ± 15 years. Proteinuria was found in 281 (41.9%) patients before TEVAR: 148 were trace, 100 were 1+ and 33 were ≥2+. Patients were classified into two groups: no proteinuria (n = 390) and proteinuria (n = 281). The baseline characteristics of the groups are presented in Table 1 . The proportion of patients with acute TBAD was 81.4%, and this was higher in patients with proteinuria (74.9% vs. 90.4%, p < 0.001). Higher CRP, lgDDI and longer hospital stay were also identified in patients with proteinuria, who had lower eGFR. In addition, patients with proteinuria were more likely to have involvement of the coeliac axis, superior mesenteric artery (SMA) or right renal artery.
The results of univariate logistic regression analysis of associations with proteinuria were presented in Table 2 . The variables, acute type, lgCRP, lgDDI, eGFR < 60 mL/min per 1.73 m 2 , coeliac axis affected, SMA affected and right renal artery affected, were associated with preoperative proteinuria. After adjustment for confounding factors, lgCRP and eGFR < 60 mL/min per 1.73 m 2 were independent predictors of proteinuria (Table 3) . The adjusted OR values were 4.99 (95% CI = 2.62-9.49, p < 0.001) and 3.48 (95% CI = 1.97-6.13, p < 0.001) for lgCRP and eGFR < 60 mL/min per 1.73 m 2 , respectively. During hospitalization, 21 patients died. In-hospital mortality was higher in patients with proteinuria (1.5% vs. 5.3%, p = 0.005; Figure 1 ). Twenty-five patients suffered a stroke, and 21 patients received dialysis treatment. There was a significant difference in the frequency of in-hospital MACEs between the two groups (5.6% vs. 11.4%, p = 0.007; Figure 1 ).
After a median 3.4 years follow-up, the post-TEVAR death rate was 10.4% (85 patients were lost to followup). Long-term mortality increased with the degree of proteinuria (linear trend test, p < 0.001). In addition, the Kaplan-Meier curve showed that the longterm cumulative mortality was significantly higher in patients proteinuria (17.2% vs. 8.2%, log-rank = 11.36, p = 0.001; Figure 2 ). Using univariate survival analysis, age, anemia, lgDDI, eGFR < 60 mL/min per 1.73 m 2 and proteinuria were risk factors for long-term mortality (Table 4 ). Multivariate analysis showed that proteinuria remained significantly associated with long-term death after adjustment for potential confounding risk factors (HR = 1.92, 95% CI = 1.16-3.19, p = 0.012; Table 4 ). Older age was also independently associated with longterm mortality (HR = 1.04, 95% CI = 1.02-1.07, p = 0.001; Table 4 ). HRs for different degrees of proteinuria are shown in Table S1 .
Discussion
This study, to our best knowledge, was the first to investigate the prognostic role of preoperative proteinuria, measured by urine dipstick test, in patients with TBAD undergoing TEVAR. lgCRP and eGFR < 60 mL/min per 1.73 m 2 were independent predictors for proteinuria. Proteinuria was independently associated with long-term mortality and could be considered as a means of risk assessment before TEVAR. The extent of proteinuria correlates with the HRs.
Despite substantial improvements in the medical treatment and surgical interventions for TBAD, in-hospital and long-term mortalities remain high [9] . In the present study, we included 671 patients undergoing TEVAR, among whom in-hospital mortality was 3.1% and longterm morality was 10.4%. Early identification of such high risk patients is essential to improve prognosis in this condition.
Proteinuria is a marker of structural damage to the glomeruli or kidney tubules and a predictor of adverse prognosis in various diseases. Muslem et al. [10] evaluated the relationship between preoperative proteinuria and poor outcomes in 173 patients undergoing continuous flow left ventricular assist device implantation. They showed that proteinuria measured by urine dipstick, was associated with a higher risk of 1-year all-cause death. In a study conducted by Wei et al. [11] , dipstick proteinuria was considered as an independent predictor of in-hospital and 1-year mortality in patients with infective endocarditis, and similar results were obtained in patients with heart failure [12] . Aortic dissection is defined as the separation of the intimal and medial layers, which may trigger malperfusion of abdominal organs, including kidneys [13] . We hypothesized that such ischemia would lead to renal dysfunction and increase the excretion of urinary protein. In this study, we included 671 patients with TBAD undergoing TEVAR, 281 (41.9%) of which had proteinuria. Furthermore, dipstick proteinuria was identified as independently associated with long-term mortality. Although the exact mechanisms underlying the relationship between proteinuria and poor outcomes in patients with TBAD remain unclear, several findings from previous studies may help to explain this association. First, proteinuria is an indicator of kidney damage. We found that eGFR was lower in patients with proteinuria. Protein filtered by the glomerulus can be taken up by tubular cells. The presence of proteinuria is attributed to impaired filtration or insufficient reabsorption [14] . The formation of AD can involve the renal artery, causing decreased blood supply to the kidney. In addition, overactivated sympathetic nervous and renin angiotensin systems during the acute phase of AD can cause renal malperfusion [15] . These changes result in renal dysfunction. Increased urinary protein excretion also indicates preexisting organic kidney disease, which is a predictor of poor prognosis in patients with TBAD [16] . Second, proteinuria has direct effects in promoting the progression of kidney damage by inducing renal tubular cell apoptosis [17] . Zhuang et al. [18] reported that mitochondrial oxidative stress is essential to proteinuria-associated kidney injury.
In addition, the interstitial inflammation and fibrosis that follow proteinuria can further damage renal function [19] . A clinical study reported that patients with proteinuria have a high risk of developing postoperative acute kidney injury [20, 21] . Third, a previous study showed that inflammatory reactions are involved in AD, particularly among patients with serious clinical symptoms and significant progression [22] . Inflammatory markers, such as CRP, are significantly elevated in patients with AD [23] . This systemic inflammation is an important factor contributing to endothelial dysfunction [24, 25] , which increases capillary permeability to serum proteins [26] . In multivariate analysis, we found that lgCRP was independently associated with proteinuria. Higher CRP represented more serious inflammation, contributing to poor outcomes in patients with acute aortic disease [27] ; therefore, proteinuria can be considered a predictor of adverse outcomes for patients with TBAD.
This study has several limitations. First, this was a retrospective study; hence, although multivariate analysis was performed, some residual risk factors may have influenced the results. Second, a urine dipstick test is not sufficiently sensitive to detect microproteinuria. Nevertheless, this test is the most convenient and widely used method to check for urine abnormalities. According to our results, pre-TEVAR proteinuria measured by urine dipstick test can be used as a risk assessment marker in patients with TBAD. Finally, urinary protein was not monitored dynamically, and it remains unclear whether amelioration of proteinuria would improve prognosis.
Conclusions
Preoperative proteinuria, defined by urine dipstick result, was identified in almost half of patients with TBAD undergoing TEVAR. The severity of inflammation and renal dysfunction may contribute to proteinuria. In addition, proteinuria was independently associated with long-term mortality and is potentially a convenient and simple risk assessment method for application prior to TEVAR.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
